RB1 Circulating Tumor DNA in the Blood of Patients with Unilateral Retinoblastoma: Before and after Intra-arterial Chemotherapy

PURPOSE: Circulating tumor DNA (ctDNA) is released by many tumors into the plasma. Its analysis has minimal procedural risk and, in many cancers, has the potential for clinical applications. In retinoblastoma, the clinical correlations of ctDNA in eyes treated without enucleation have not been studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Francis, Jasmine H., Gobin, Y. Pierre, Brannon, A. Rose, Swartzwelder, Christina E., Berger, Michael F., Mandelker, Diana L., Walsh, Michael F., Dunkel, Ira J., Abramson, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560637/
https://www.ncbi.nlm.nih.gov/pubmed/36247821
http://dx.doi.org/10.1016/j.xops.2021.100042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560637/
https://www.ncbi.nlm.nih.gov/pubmed/36247821
http://dx.doi.org/10.1016/j.xops.2021.100042

Ejemplares similares